STERIS plc
About STERIS plc
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $5.9B
- Net income
- $782.3M
- Total assets
- $10.7B
- Market cap
- $20.7B
- Gross margin
- 44.2%
- Operating margin
- 18.6%
- Net margin
- 13.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $5.9B
- Cost of revenue
- $3.3B
- Gross profit
- $2.6B
- Operating expenses
- $1.5B
- Operating income
- $1.1B
- Income tax
- $262.2M
- Net income
- $785.1M
- EPS (basic)
- $7.97
- EPS (diluted)
- $7.93
Balance sheet
- Total assets
- $10.7B
- Current assets
- $2.4B
- Total liabilities
- $3.5B
- Current liabilities
- $1.1B
- Shareholders’ equity
- $7.2B
Cash flow
- Operating cash flow
- $1.3B
- Investing cash flow
- -$512.5M
- Financing cash flow
- -$568.2M
- Net cash flow
- $267.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $20.7B
- P/E ratio
- 26.5
- EPS (diluted)
- $7.93
- Dividend yield
- 1.2%
- Shares outstanding
- 98.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 2, 1992
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $782.3M in FY2026.
- Revenue grew 29% from FY2022 to FY2026.
- Gross margin of 44.2%, net margin 13.2%.
- Trading 22% below its 52-week high.
- Pays a dividend yielding about 1.2% annually.
- Valued at a price-to-earnings (P/E) ratio of 26.5.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review STERIS plc.
Write a review
News about STERIS plc
News & sentiment via Polygon.io
